Intelligence Platform

Patents

Browse 710 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8071535

Guanidinium derivatives for improved cellular transport

The Regents of the University of California · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071545

Therapies and compositions for controlling the stress mechanism and for stabilizing hemost

Lewis S. Coleman, MD, Inc. · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071556

Peptide substance revealing a stress protective effect, pharmaceutical composition on its

Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8057810

Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on

Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039489

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039008

Identification of residues critical for the function of the vibrio cholerae virulence regu

The Board of Regents of the University of Texas System · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8029788

Variants of humanized anti-carcinoma MAb CC49

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030493

Monovalent and divalent salts of N-(5-hydroxynicotinoil) -L-glutamic acid exhibiting psych

Obschestvo S Ogranichennoy Otvetstvennostyu “Natsionalnaya Isseldovatelskaya Kompaniya” · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998928

Method of treatment of type-1 diabetes with a humanin analogue

The Regents of the University of California · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994165

Aryl aniline derivatives as β2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7988977

Modified live Aeromonas hydrophila vaccine for aquatic animals

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7959929

Materials and methods for respiratory disease control in canines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7960385

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928147

Antimicrobial wash and carrier solutions, and uses thereof

Teva Animal Health, Inc. · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919607

Nucleic acids encoding humanized anti-tag 72 CC49 antbodies

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915396

Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized an

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906484

Complex for transferring an anionic substance into a cell

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7897763

Process for the preparation of substituted phenylalanines

LEXICON PHARMACEUTICALS, INC. · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7887818

Neospora caninum vaccine

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7887812

Live attenuated Leishmania vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858123

Inorganic materials for hemostatic modulation and therapeutic wound healing

The Regents of the University of California · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855291

Process for the preparation of substituted phenylalanines

LEXICON PHARMACEUTICALS, INC. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855276

Framework residue substituted humanized COL-1 antibodies and their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7851449

Peptide, pharmaceutical composition, and a method of treating microcirculation disorders

Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted